Expression of class III {beta}-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/16061864

Clin. Cancer Res. 2005 Aug 1 11 15 5481-6

Download in:

View as

General Info

PMID
16061864